Cannabidiol with clobazam

Indication

Cannabidiol with clobazam for treating seizures associated with Dravet syndrome (NICE TA614)

Red

Brand:

Nice TA:

614

Commissioning responsibility:

NHS England

PbR excluded:

No

BNF chapter:

Central nervous system

Background

1.1 Cannabidiol with clobazam is recommended as an option for treating seizures associated with Dravet syndrome in people aged 2 years and older, only if:

• the frequency of convulsive seizures is checked every 6 months, and cannabidiol is stopped if the frequency has not fallen by at least 30% compared with the 6 months before starting treatment

• the company provides cannabidiol according to the commercial arrangement.

Recommendation

LSCMMG Recommendation:

Red

Reason for decision:

Specialist medicine

Supporting documents:

Decisions of Lancashire local decision making groups

BwD	BP	CSR	EL	FW	GP	MB	WL
Pending	Pending	Pending	Pending	Pending	Pending	Pending	Pending

What do the colours mean?

Last Updated: 14 - Jan - 2020